Composition:
Daclatasvir (60mg)
Daclahep contains daclatasvir 60 mg tablet (equivalent to daclatasvir dihydrochloride). Daclatasvir is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir for treatment of chronic HCV genotype 3 infection.
*To be consumed as directed by physician.
